CPA
NEPH icon

Cowen Prime Advisors’s Nephros NEPH Stock Holding History

Cowen Prime Advisors’s Portfolio NEPH Stock Details NEPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-42,500
Closed -$65K – 176
2022
Q2 		$65K Sell
42,500
-37,900
-47% -$102K 0.04% 107
2022
Q1 		$354K Sell
80,400
-552,650
-87% -$2.62M 0.15% 68
2021
Q4 		$3.73M Sell
633,050
-27,100
-4% -$198K 1.27% 18
2021
Q3 		$5.79M Buy
660,150
+33,700
+5% +$292K 2.15% 11
2021
Q2 		$6.36M Buy
626,450
+3,700
+0.6% +$30.9K 2.31% 12
2021
Q1 		$4.14M Buy
622,750
+47,673
+8% +$376K 1.57% 14
2020
Q4 		$4.93M Buy
575,077
+266,068
+86% +$1.8M 2.19% 11
2020
Q3 		$2.23M Buy
309,009
+266,509
+627% +$1.95M 1.09% 22
2020
Q2 		$65K Sell
42,500
-112,300
-73% -$890K 0.04% 107
2020
Q1 		$975K Buy
+154,800
New +$1.31M 0.6% 37

Other funds holding NEPH

WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.88% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $451M AUM 66.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
EP
Elkhorn Partners Omaha, Nebraska $117M AUM 28.12% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Cowen Prime Advisors's NEPH Position: Q3 2022 in Review

Cowen Prime Advisors sold out of Nephros (NEPH) in Q3 2022, closing a stake of 42,500 shares — an estimated $65K sold.

Cowen Prime Advisors first reported a position in NEPH in Q1 2020 and held it in 10 quarters. The position peaked at $6.36M in Q2 2021. 18 funds tracked by Wall St. Rank hold NEPH as of Q3 2022.

  • Cowen Prime Advisors reported no remaining Nephros position as of Q3 2022 after selling out during the quarter.
  • Cowen Prime Advisors sold 42,500 Nephros shares in Q3 2022, an estimated $65K.
  • Cowen Prime Advisors first reported a position in Nephros in Q1 2020 and held it in 10 quarters.
  • Cowen Prime Advisors's Nephros position peaked at $6.36M in Q2 2021.
  • 18 funds tracked by Wall St. Rank held Nephros as of Q3 2022.

Based on Cowen Prime Advisors's 13F filing for Q3 2022, filed 7 Nov 2022.